Agilon Health, Inc. (AGL) Insider Trading Activity

NYSE$28.3-1.75 (-5.82%)
Market Cap
$499.01M
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
217 of 876
Rank in Industry
9 of 39

AGL Insider Trading Activity

AGL Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$351,991
2
100
Sells
$0
0
0

Related Transactions

Shaker BenjaminChief Markets Officer
1
$301,050
0
$0
$301,050
Wulf John Williamdirector
1
$50,941
0
$0
$50,941

About Agilon Health, Inc.

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Insider Activity of Agilon Health, Inc.

Over the last 12 months, insiders at Agilon Health, Inc. have bought $351,991 and sold $0 worth of Agilon Health, Inc. stock.

On average, over the past 5 years, insiders at Agilon Health, Inc. have bought $241,888 and sold $1.23B worth of stock each year.

Highest buying activity among insiders over the last 12 months: Shaker Benjamin (Chief Markets Officer) — $301,050. Wulf John William (director) — $50,941.

The last purchase of 500,000 shares for transaction amount of $301,050 was made by Shaker Benjamin (Chief Markets Officer) on 2026‑03‑02.

List of Insider Buy and Sell Transactions, Agilon Health, Inc.

2026-03-02PurchaseShaker BenjaminChief Markets Officer
500,000
0.1232%
$0.60
$301,050
-2.79%
2025-11-12PurchaseWulf John Williamdirector
81,000
0.0184%
$0.63
$50,941
+4.97%
2025-03-14PurchaseShaker BenjaminChief Markets Officer
11,786
–
$0
$0
-72.59%
2025-03-14PurchaseSell StevenCEO & President
42,426
–
$0
$0
-72.59%
2025-03-14PurchaseVenkatachaliah GirishChief Technology Officer
9,429
–
$0
$0
-72.59%
2024-12-13PurchaseMcLoughlin Karendirector
25,000
0.0061%
$2.20
$55,085
-2.68%
2024-12-11PurchaseBattaglia Silvanadirector
25,062
0.0061%
$2.01
$50,269
+9.55%
2024-12-09PurchaseMCKENZIE DIANAdirector
7,500
0.0018%
$2.20
$16,489
-2.68%
2024-12-05PurchaseWulf John Williamdirector
45,000
0.0107%
$2.18
$98,145
-1.36%
2024-11-25PurchaseMCKENZIE DIANAdirector
12,500
0.003%
$2.28
$28,474
-3.10%
2024-09-12PurchaseSell StevenCEO & President
20,000
0.0049%
$3.36
$67,188
-24.47%
2024-03-14PurchaseShaker BenjaminChief Markets Officer
274,455
–
$0
$0
-26.10%
2024-03-14PurchaseDesai VeeralChief Strategy & Dev. Officer
11,956
–
$0
$0
-26.10%
2024-03-14PurchaseKornitzer BenjaminChief Med. & Quality Officer
5,434
–
$0
$0
-26.10%
2024-03-14PurchaseBensley TimothyChief Financial Officer
14,945
–
$0
$0
-26.10%
2024-03-14PurchaseVenkatachaliah GirishChief Technology Officer
5,434
–
$0
$0
-26.10%
2023-11-29PurchaseSchwaneke Jeffrey A.Chief Financial Officer
22,300
0.0057%
$11.22
$250,206
-47.43%
2023-09-13SaleShaker BenjaminChief Markets Officer
18,750
0.0047%
$18.00
$337,455
-63.93%
2023-09-12SaleShaker BenjaminChief Markets Officer
18,750
0.0047%
$18.05
$338,481
-63.36%
2023-09-11SaleGertsch TimothyChief Accounting Officer
26,250
0.0065%
$18.61
$488,616
-64.76%
Total: 136
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Shaker BenjaminChief Markets Officer
1367674
8.236%
$41.1M335
Wulf John Williamdirector
365857
2.2032%
$10.99M23
<0.0001%
CD&R Vector Holdings, L.P.
194611308
1171.9342%
$5.85B01
CD&R Investment Associates IX, Ltd.10 percent owner
100000000
602.1922%
$3B03
Mansukani Sharaddirector
1229356
7.4031%
$36.94M01
Sell StevenCEO & President
370873
2.2334%
$11.14M31
<0.0001%
Desai VeeralChief Strategy & Dev. Officer
311541
1.8761%
$9.36M115
Venkatachaliah GirishChief Technology Officer
158431
0.9541%
$4.76M20
McLoughlin Karendirector
73166
0.4406%
$2.2M10
<0.0001%
Battaglia Silvanadirector
66144
0.3983%
$1.99M10
+9.55%
Kornitzer BenjaminChief Med. & Quality Officer
63941
0.385%
$1.92M145
MCKENZIE DIANAdirector
58819
0.3542%
$1.77M20
<0.0001%
Bensley TimothyChief Financial Officer
50116
0.3018%
$1.51M10
Richards Claydirector
28656
0.1726%
$861,112.8010
<0.0001%
Schwaneke Jeffrey A.Chief Financial Officer
22300
0.1343%
$670,115.0010
<0.0001%
Gertsch TimothyChief Accounting Officer
17121
0.1031%
$514,486.0501
Dombro LisaExper. & Innovation Officer
11956
0.072%
$359,277.8001
Gourdine Michelle Adirector
11956
0.072%
$359,277.8010
<0.0001%
Halkias TheodoreChief Business Officer
5434
0.0327%
$163,291.7005
Danieley JoanChief Administrative Officer
5434
0.0327%
$163,291.7003
SMITH MICHAEL L
4126
0.0248%
$123,986.3001
Sobotka GlennChief Accounting Officer
3260
0.0196%
$97,963.0001
*Gray background shows insiders who have made transactions during last year

AGL Institutional Investors: Active Positions

Increased Positions108+44.26%58M+15.01%
Decreased Positions106-43.44%70M-18.2%
New Positions56New9MNew
Sold Out Positions47Sold Out16MSold Out
Total Postitions246+0.82%371M-3.19%

AGL Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Clayton, Dubilier & Rice, Llc$67,400.0024.1%100M00%2025-09-30
Morgan Stanley$40,025.0014.31%59.38M+2M+3.76%2025-09-30
North Peak Capital Management, Llc$23,202.008.3%34.42M+34MNew2025-09-30
Vanguard Group Inc$16,373.005.85%24.29M-6M-19.82%2025-09-30
Blackrock, Inc.$16,309.005.83%24.2M-575,483-2.32%2025-09-30
Fmr Llc$10,545.003.77%15.65M-24M-60.21%2025-09-30
Centerbook Partners Lp$7,702.002.75%11.43M+9M+492.43%2025-09-30
D. E. Shaw & Co., Inc.$6,736.002.41%9.99M+9M+600.86%2025-09-30
Capital World Investors$5,637.002.02%8.36M-37M-81.65%2025-09-30
Capital International Investors$5,549.001.98%8.23M-2M-16.79%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.